article Related Topics:
Prion :: Prion_Diseases
 

This article is about the infectious particles known as prions; for the bird, see Prion (bird).

A prion (IPA: audio) — short for proteinaceous infectious particle — is a unique type of infectious agent, as it is made only of protein. Prions are abnormally-structured forms of a host protein, which are able to convert normal molecules of the protein into the abnormal structure. Unlike other pathogens, prions cannot be denatured by protease, heat, radiation, and formalin treatments. Though the exact mechanisms of their actions and propagation are unknown, it is now commonly accepted that prions are responsible for a number of previously known but little-understood diseases classified as transmissible spongiform encephalopathies (TSEs). These include scrapie (a disease of sheep), Creutzfeldt-Jakob disease (CJD), and bovine spongiform encephalopathy (BSE or mad cow disease). These diseases affect the structure of brain tissue and all are fatal and untreatable.

Proteins showing prion behaviour are also found in some fungi. Some fungal prions may not be associated with any disease state and may have an evolutionary advantage for their hosts. So far all prions discovered are believed to infect and propagate by formation of an amyloid fold. However, since any infectious protein particle would be defined as a prion, other mechanisms may be possible.

PrP and the prion hypothesis


The theory that some TSEs are caused by an infectious agent made solely of protein was developed in 1960s by radiation biologist Tikvah Alper and physicist J.S. Griffith.}}}} This theory was developed to explain the discovery that the mysterious infectious agent causing the diseases scrapie and Creutzfeldt-Jakob Disease resisted ultraviolet radiation (which breaks down nucleic acids - present in viruses and all living things), yet responded to agents that disrupt proteins.

The first glimpse came from virologist Patricia Merz in 1981 at the Institute for Basic Research in Developmental Disabilities at Staten Island, N.Y. who observed strange fibrils in scrapie-infected mouse brains. A breakthrough occurred in 1982 when researchers led by Stanley B. Prusiner of the University of California, San Francisco purified infectious material and confirmed that the infectious agent consisted mainly of a specific protein. Prusiner coined the word "prion" as a name for the infectious agent, by combining the first two syllables of the words "proteinaceous" and "infectious." While the infectious agent was named a prion, the specific protein that the prion was made of was named PrP, an abbreviation for "prion-related protein" (also "protease-resistant protein"). Prusiner received the Nobel Prize in Physiology or Medicine in 1997 for this research.}}

Further research showed that PrP is found throughout the body, even in healthy people and animals. However, the PrP found in infectious material (i.e. the PrP that forms prions) has a different structure and is resistant to proteases, the enzymes in the body that can normally break down proteins. The normal form of the protein is called PrPC, while the infectious form is called PrPSc— the 'C' refers to 'cellular' PrP, while the 'Sc' refers to 'scrapie,' a prion disease occurring in sheep. PrPC is found on the membranes of cells, though its normal function has not been fully resolved. Since the original hypothesis was proposed, a gene for PrP has been isolated: the PRNP gene.

Some prion diseases (TSEs) can be inherited, and in all inherited cases there is a mutation in the Prnp gene. Many different Prnp mutations have been identified and it is thought that the mutations somehow make PrPC more likely to spontaneously change into the PrPSc (disease) form. TSEs are the only known diseases that can be sporadic, genetic or infectious; for more information see the article on TSEs.

Although the identity and general properties of prions are now well-understood, the mechanism of prion infection and propagation remains mysterious. It is generally assumed that PrPSc directly interacts with PrPC to cause the normal form of the protein to rearrange its structure (enlarge the diagram above for an illustration of this mechanism). One idea, the "Protein X" hypothesis, is that an as-yet unidentified cellular protein (Protein X) enables the conversion of PrPC to PrPSc by bringing a molecule of each of the two together into a complex.

Prior to Alper's insight, all known pathogens (bacteria, viruses, etc.) contained nucleic acids that are necessary for reproduction. The prion hypothesis was highly controversial, because it seemed to contradict the so-called "central dogma of modern biology" that asserts all living organisms use nucleic acids to reproduce. The "protein-only hypothesis" — that a protein structure (which, unlike DNA, has no obvious means of replication) could reproduce itself — was initially met with skepticism. However, evidence has steadily accumulated in support of this hypothesis, and it is now widely accepted. Rather than contradicting the central role of DNA, however, the prion hypothesis suggests a special case in which merely changing the shape, or conformation, of a protein (without changing its amino acid sequence) can alter its biological properties - a form of Lamarckian evolution.

Prions in yeast and other fungi


Prion-like proteins that behave in a similar way to PrP are found naturally in some fungi and non-mammalian animals. Some of these are not associated with any disease state and may have a useful role. Research into fungal prions has given strong support to the protein-only hypothesis for mammalian prions, as it shows that the prion form of a protein can directly convert the normal form of that protein. It has also shed some light on prion domains, which are regions in a protein that promote the conversion. Fungal prions have helped to suggest mechanisms of conversion that may apply to all prions.

Molecular properties of prions


A great deal of our knowledge of how prions work at a molecular level comes from detailed biochemical analysis of yeast prion proteins. A typical yeast prion protein contains a region (protein domain) with many repeats of the amino acids glutamine (Q) and asparagine (N); these Q/N-rich domains form the core of the prion's structure. Ordinarily, yeast prion domains are flexible and lack a defined structure. When they convert to the prion state, several molecules of a particular protein come together to form a highly structured amyloid fiber. The end of the fiber acts as a template for the free protein molecules, causing the fiber to grow. Small differences in the amino acid sequence of prion-forming regions lead to distinct structural features on the surface of prion fibers. As a result, only free protein molecules that are identical in amino acid sequence to the prion protein can be recruited into the growing fiber. This "specificity" phenomenon may explain why transmission of prion diseases from one species to another, such as from sheep to cows or from cows to humans is a rare event.

The mammalian prion proteins do not resemble the prion proteins of yeast in their amino acid sequence. Nonetheless, the basic structural features (formation of amyloid fibers and a highly specific barrier to transmission between species) are shared between mammalian and yeast prions. The prion variant responsible for mad cow disease has the remarkable ability to bypass the species barrier to transmission.

The figure at right shows a model of two conformations of prion; on the left is the known, normal conformation of the structured C-terminal region of PrPC. (to explore/download see the RCSB Protein Databank). The N-terminal region is not shown here for having a flexible structure in aqueous solution. The structured domain shown is mainly made of three spirals called alpha helices (pink), with two short 'flat' regions of beta sheet structure (green). On the right is a proposed model of how the abnormal PrPSc form might look. Although the exact 3D structure of PrPSc is not known, there is increased β sheet content (green arrows) in the prion version of the molecule. These β sheets are thought to lead to amyloid aggregation.

Dissent


Mark Purdy and Doctor David R. Brown have suggested that metal ion interactions with prion protein might be relevant to progression of prion-mediated disease. Purdy cites epidemiological studies of clusters of prion disease in locales with low soil concentrations of copper as evidence.

Classification


Mammalian prions, agents of spongiform encephalopathies
ICTVdb Code Disease name Natural host Prion name PrP isoform
90.001.0.01.001. Scrapie Sheep and goats Scrapie prion OvPrPSc
90.001.0.01.002. Transmissible mink encephalopathy (TME) Mink TME prion MkPrPSc
90.001.0.01.003. Chronic wasting disease (CWD) Mule Deer and Red Deer CWD prion MDePrPSc
90.001.0.01.004. Bovine spongiform encephalopathy (BSE) Cattle BSE prion BovPrPSc
90.001.0.01.005. Feline spongiform encephalopathy (FSE) Cats FSE prion FePrPSc
90.001.0.01.006. Exotic ungulate encephalopathy (EUE) Nyala and greater kudu EUE prion NyaPrPSc
90.001.0.01.007. Kuru Humans Kuru prion HuPrPSc
90.001.0.01.008. Creutzfeldt-Jakob disease (CJD) Humans CJD prion HuPrPSc
  (New) Variant Creutzfeldt-Jakob disease (vCJD, nvCJD) Humans vCJD prion HuPrPSc
90.001.0.01.009. Gerstmann-Sträussler-Scheinker syndrome (GSS) Humans GSS prion HuPrPSc
90.001.0.01.010. Fatal familial insomnia (FFI) Humans FFI prion HuPrPSc

References


External links


Biochemistry | Genetics | Proteins | Prions

Прион | Prion | Prion | Prioonid | Prión | Priono | Prion (protéine) | Prión | 프리온 | Prion | Prione | פריון | Prionas | Prion | Prion | プリオン | Prion | Príon | Прионы | Prión | Prioni | Prion | 朊毒體 | Приони

 

This article is licensed under the GNU Free Documentation License. It uses material from the "Prion".

Home Pageartsbusinesscomputersgameshealthhospitalshomekids & teensnewsphysiciansrecreationreferenceregionalscienceshoppingsocietysportsworld